Jump to Content
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Featured Online Content
Supplements
NCCN Meeting Highlights
JNCCN In the News
NCCN News
Highlights of the NCCN Oncology Research Program
Video Roundtables
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Conexiant (FKA Harborside)
Reducing Disparities in Cancer Care
Search
Close
Advanced Search
Help
Volume 23 (2025): Issue 5 (May 2025)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
NCCN Guidelines® Insights
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
Oncology Watch
Precious Time
The Last Word
Breaking Down Silos: The Financial Toxicity Tumor Board as a Model for Addressing Treatment-Related Financial Burden
Original Research
Trajectory of Global Mental Health and Global Physical Health in Breast Cancer Survivorship
Management and Outcomes of
Clostridioides difficile
Infection in Patients on Immune Checkpoint Inhibitors
Trends in Prevalence and Correlates of Alcohol Use Disorder Diagnoses Among US Adult Cancer Survivors: Serial Cross-Sectional Analysis
The Financial Toxicity Tumor Board: 5-Year Update on Practice and a Guide to Implementation
Association of Hospital Flagship System Affiliation on Surgical Outcomes Following Complex Cancer Surgery
Cardiovascular Adverse Events and Associated Costs of CDK4/6 Inhibitors in Patients With Breast Cancer
Reviews
Evolving Therapeutics for Resectable Esophageal Adenocarcinoma
Biomarker-Driven Approach to the Treatment of Metastatic Gastric or Gastroesophageal Adenocarcinoma
Correspondence
Letter to the Editor: Are We Asking the Right Question for New Biomarkers – “Ready for Prime Time” Versus Demonstrated Clinical Utility?
Authors’ Reply to the Letter to the Editor by Kim et al: Are We Asking the Right Question for New Biomarkers – “Ready for Prime Time” Versus Demonstrated Clinical Utility?
Letter to the Editor: Advancing Prognostic Stratification in PSCC: Developing Predictive Models as the Next Pivotal Step
Authors’ Reply to the Letter to the Editor by May et al: Optimized Prognostic Stratification in PSCC
Departments
Highlights of the NCCN Oncology Research Program
NCCN News
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/view/journals/jnccn/23/5/jnccn.23.issue-5.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Search
Issue
Journal
[18.97.14.83]
18.97.14.83
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size